United States · FDA National Drug Code directory
LAMOTRIGINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-049_7f173ac5-3a79-4426-ae9b-7149427975ab
- Product NDC
- 13668-049
- Form
- TABLET
- Composition / generic term
- LAMOTRIGINE
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090127
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (13668-049-01) · 13668-049-01
- 500 TABLET in 1 BOTTLE (13668-049-05) · 13668-049-05
- 1300 TABLET in 1 BOTTLE (13668-049-13) · 13668-049-13
- 30 TABLET in 1 BOTTLE (13668-049-30) · 13668-049-30
- 60 TABLET in 1 BOTTLE (13668-049-60) · 13668-049-60
- 90 TABLET in 1 DOSE PACK (13668-049-64) · 13668-049-64
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →